Release of peptide YY and inhibition of gastric acid secretion by long-chain and medium-chain triglycerides but not by sucrose polyester in men

European Journal of Clinical Investigation

Volumn 28, Issue 2, 1998, Pages 123-130

  Maas, M I M ^a   Hopman, W P M ^a   Katan, M B ^a,b   Jansen, J B M J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Gastric acid secretion; Long chain triglycerides; Medium chain triglycerides; Peptide YY; Sucrose polyester

Indexed keywords

GASTRIN; LONG CHAIN TRIACYLGLYCEROL; MEDIUM CHAIN TRIACYLGLYCEROL; PEPTIDE YY; SUCROSE POLYESTER;

ADULT; ARTICLE; CONTROLLED STUDY; GASTRIN BLOOD LEVEL; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; IMMUNOREACTIVITY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STOMACH ACID SECRETION; VOLUNTEER;

ADULT; ANTI-ULCER AGENTS; DIETARY FATS; DUODENUM; EATING; FATTY ACIDS; FEMALE; GASTRIC ACID; GASTRINS; HUMANS; MALE; PEPTIDE YY; PERFUSION; SUCROSE; TRIGLYCERIDES;

EID: 0031910146     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1998.00255.x     Document Type: Article

References (61)

1. Kosaka T, Lim RKS. Demonstration of the humoral agent in fat inhibition of gastric secretion. Proc Soc Exp Biol Med 1930; 27: 890-1.
2. Jebbink MCW, Lamers CBHW, Moody DM, Rovati LC, Jansen JBMJ. Effect of loxiglumide on basal and gastrin- and bombesin-stimulated gastric acid and serum gastrin levels. Gastroenterology 1992; 103: 1215-20.
3. Konturek JW, Konturek SJ, Domschke W. Cholecystokinin in the control of gastric acid secretion and gastrin release in response to a meal at low and high pH in healthy subjects and duodenal ulcer patients. Scand J Gastroenterol 1995; 30: 738-44.
4. Beglinger C, Hildebrand P, Meier R et al. A physiological role for cholecystokinin as a regulator of gastrin secretion. Gastroenterology 1992; 103: 490-5.
5. Corazziari E, Solomon TE, Grossman MI. Effect of ninety-five percent pure cholecystokinin on gastrin-stimulated acid secretion in man and dog. Gastroenterology 1979; 77: 91-5.
6. Lloyd KCK, Raybould HE, Walsh JH. Cholecystokinin inhibits gastric acid secretion through type 'A' cholecystokinin receptors and somatostatin in rats. Am J Physiol 1992; 263: G287-2.
7. Lloyd KCK, Maxwell V, Kovacs TOG, Miller J, Walsh JH. Cholecystokinin receptors antagonist MK-329 blocks intestinal fat-induced inhibition of meal-stimulated gastric acid secretion. Gastroenterology 1992; 102: 131-8.
8. Schmidt WE, Schenk S, Nustede R, Holst JJ, Fölsch UR, Creutzfeldt W. Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of gastrin in humans. Gastroenterology 1994; 107: 1610-20.
9. Verhulst ML, Gielkens HAJ, Hopman WP et al. Loxiglumide inhibits cholecystokinin stimulated somatostatin secretion and simultaneously enhances gastric acid secretion in humans. Regul Pept 1994; 53: 185-93.
10. Chey WY, Kim MS, Lee KY, Chang TM. Secretin is an enterogastrone in the dog. Am J Physiol 1981; 240: G239-44.
11. Kim YC, Lee KY, Chey WY. Role of secretin on postprandial gastrin release in the dog: A further study. Surgery 1981; 90: 504-8.
12. Kleibeuker JH, Eysselein VE, Maxwell VE, Walsh JH. Role of endogenous secretin in acid-induced inhibition of gastric function. J Clin Invest 1984; 73: 526-32.
13. Seal AM, Meloche RM, Liu YQE, Buchan AMJ, Brown JC. Effects of monoclonal antibodies to somatostatin on somatostatin-induced and intestinal fat-induced inhibition of gastric acid secretion in the rat. Gastroenterology 1987; 92: 1187-92.
14. Seal A, Yamada T, Debas H et al. Somatostatin-14 and -28: clearance and potency on gastric function in dogs. Am J Physiol 1982; 243: G97-102.
15. Park J, Chiba T, Yamada T. Mechanisms for direct inhibition of canine gastric parietal cells by somatostatin. J BiolChem 1987; 262: 14190-6.
16. Colturi TJ, Unger RH, Feldman M. Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release, and islet cell function. J Clin Invest 1984; 74: 417-23.
17. Schubert ML, Edwards NF, Arimura A, Makhlouf GM. Paracrine regulation of gastric acid secretion by fundic somatostatin. Am J Physiol 1987; 252: G485-90.
18. Schubert ML, Hightower J, Makhlouf GM. Linkage between somatostatin and acid secretion: evidence from use of pertussis toxin. Am J Physiol 1989; 256: G418-22.
19. McIntosh CHS, Tang CL, Malcolm AJ, Ho M, Kwok YN, Brown JC. Effect of a purified somatostatin monoclonal antibody and its Fab fragments on gastrin release. Am J Physiol 1991; 260: G489-98.
20. Chiba T, Yamada T. Gut somatostatin. In: Walsh JH, Dockray GJ eds. Gut Peptides: Biochemistry and Physiology, 3rd edn. New York: Raven Press, 1994; 123-45.
21. Pappas TN, Debas HT, Goto Y, Taylor IL. Peptide YY inhibits meal-stimulated pancreatic and gastric secretion. Am J Physiol 1985; 248: G118-23.
22. Pappas TN, Debas HT, Taylor IL. Enterogastrone-like effect of peptide YY is vagally mediated in the dog. J Clin Invest 1986; 77: 49-53.
23. Greeley GH, Guo Y-S, L.Luis F, Singh P, Thompson JC. Inhibition of gastric acid secretion by peptide YY is independent of gastric somatostatin release in the rat. Proc Soc Exp Biol Med 1988; 189: 325-8.
24. Adrian TE, Savage AP, Sagor GR et al. Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology 1985; 89: 494-9.
25. Maxwell V, Shulkes A, Brown JC, Solomon TE, Walsh JH, Grossman MI. Effect of gastric inhibitory polypeptide on pentagastrin stimulated acid secretion in man. Dig Dis Sci 1980; 25: 113-16.
26. Pederson RA. Gastric inhibitory peptide. In: Walsh JH, Dockray GJ eds. Gut Peptides, Biochemistry and Physiology, 3rd edn. New York: Raven Press, 1994: 217-59.
27. Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W. Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1[7-36 amide] infused at near physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects. Digestion 1992; 52: 214-21.
28. Mogard MH, Maxwell V, Sytnik B, Walsh JH. Regulation of gastric acid secretion by neurotensin in man. J Clin Invest 1987; 80: 1064-7.
29. Maas MIM, Hopman WPM, Katan MB, Jansen JBMJ. Inhibition of gastrin-stimulated gastric acid secretion by medium-chain triglycerides and long-chain triglycerides in healthy young men. Regul Pept 1996; 66: 203-10.
30. Hopman WPM, Jansen JBMJ, Rosenbusch G, Lamers CBHW. Effect of equimolar amounts of long-chain triglycerides and medium-chain triglycerides on plasma cholecystokinin and gallbladder contraction. Am J Clin Nutr 1984; 39: 356-9.
31. Guo Y-S, Fujimura M, L.Luis F, Tsong Y, Greeley GH, Thompson JC. Inhibitory action of peptide YY on gastric acid secretion. Am J Physiol 1987; 253: G298-302.
32. Guo Y-S, Singh P, Gomez G, Greeley GH, Thompson JC. Effect of peptide YY on cephalic, gastric, and intestinal phases of gastric acid secretion and on the release of gastrointestinal hormones. Gastroenterology 1987; 92: 1202-8.
33. Eissele R, Koop H, Arnold R. Effect of peptide YY on gastric acid secretion, gastrin and somatostatin release in the rat. Z Gastroenterology 1990; 28: 129-31.
34. Adrian TE, Ferri G-L, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 1985; 89: 1070-7.
35. Greeley GH, Jeng J, Gomez G et al. Evidence for regulation of peptide-YY release by the proximal gut. Endocrinology 1989; 124: 1438-43.
36. Aponte GW, Fink AS, Meyer JH, Tatemoto K, Taylor IL. Regional distribution and release of peptide YY with fatty acids of different chain length. Am J Physiol 1985; 249: G745-50.
37. Maas MIM, Hopman WPM, Van der Wijk T, Katan MB, Jansen JBMJ. Sucrose polyester does not inhibit gastric acid secretion or stimulate cholecystokinin release in men. Am J Clin Nutr 1997; 65: 761-5.
38. Jansen JBMJ, Lamers CBHW. Serum gastrin responses to bombesin and food in patients with hypergastrinaemia Dig Dis Sci 1982; 27: 303-7.
39. Hassan MA, Hobsley M. Positioning of subject and of nasogastric tube during a gastric secretion study. BMJ 1970; 1: 458-60.
40. Jansen JB, Lamers CB. Radioimmunoassay of cholecystokinin: production and evaluation of antibodies. J Clin Chem Clin Biochem 1983; 21: 387-94.
41. Polson A, von Wechmar MB, van Regenmortel MHV. Isolation of viral IgY antibodies from yolks of immunized hens. Immunol Commun 1980; 9: 475-93.
42. Jansen JBMJ, Lamers CBHW. Effect of changes in serum calcium on secretin-stimulated serum gastrin in patients with Zollinger-Ellison syndrome. Gastroenterology 1982; 83: 173-8.
43. Armitage P, Berry G. Statistical Methods in Medical Research, 3rd edn. London: Blackwell Science, 1996.
44. Shapiro SS, Francia RS. An approximate analysis of variance test for normality. J Am Stat Assoc 1972; 67: 215-16.
45. Hommel G. Multiple test procedures for arbitrary dependence structures. Metrika 1986; 33: 321-36.
46. Bland JM, Altman DG. Calculating correlation coefficients with repeated observations. Part 1. Correlation within subjects. BMJ 1995; 310: 446.
47. Grandt D, Schimiczek M, Beglinger G et al. Two molecular forms of Peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept 1994; 51: 151-9.
48. Gomez G, Padilla L, Udupi V et al. Regulation of peptide YY homeostasis by gastric acid and gastrin. Endocrinology 1996; 137: 1365-9.
49. Hunt JNA. possible relation between the regulation of gastric emptying and food intake. Am J Physiol 1980; 239: G1-4.
50. Hunt JN, Cash R, Newland P. Energy density of food, gastric emptying and obesity. Am J Physiol Nutr 1987; 31 (Suppl. 10): S259-60.
51. Hopman WPM, Thimister PWL, Maas MIM, van Battum PLH, Jansen JBMJ. Plasma PYY in response to intraduodenal amino acids with or without cholestyramine; role of cholecystokinin (abstract). Regul Pept 1996; 64: 72.
52. Edelbroek M, Horowitz M, Maddox A, Bellen J. Gastric emptying and intragastric distribution of oil in the presence of a liquid or a solid meal. J Nucl Med 1992; 33: 1283-90.
53. Ohneda A, Kobayashi T, Nihei J. Response of gastric inhibitory polypeptide to fat ingestion in normal dogs. Regul Pept 1984; 8: 123-30.
54. O'Halloran DJ, Nikou GC, Kreyman B, Ghatei MA, Bloom SR. Glucagon-like peptide-1 (7-36)-NH2: a physiological inhibitor of gastric acid secretion in man. J Endocrinol 1990; 126: 169-73.
55. Layer P, Holst JJ, Grandt D, Goebell H. Ileal release of glucagon-like peptide (GLP-1). Association with inhibition of gastric acid secretion in humans. Dig Dis Sci 1995; 40: 1074-82.
56. McFadden DW, Rudnicki M, Nussbaum MS, Balasubramaniam A, Fischer JE. Independent release of peptide YY (PYY) into the circulation and ileum lumen of the awake dog. J Surg Res 1989; 46: 380-5.
57. Hashimoto T, L.Luis F, Gomez G, Hill FLC, Greeley GH, Thompson JC. Intracolonic fat inhibits gastric acid secretion independent of gastrin release in the dog. Dig Dis Sci 1991; 36: 888-92.
58. Kuvshinoff BW, Rudnicki M, McFadden DW. The effect of SMS-201-995 on meal and CCK-stimulated peptide YY release. J Surg Res 1991; 50: 425-9.
59. Hashimoto Y, Sano I, Nagahata Y et al. Inhibitory effect of peptide YY on gastric acid output in rats. Scand J Gastroenterol 1989; 24 (Suppl. 162), 134-7.
60. Zhao XT, Walsh JH, Lloyd KCK, Wong H, Lin HC. CCK but not PYY is the enterogastrone for proximal gut fat (abstract). Gastroenterology 1997; 112: A342.
61. Olsen O, Christansen J. Inhibition of human gastric acid secretion by peptide YY and secretin. Digestion 1990; 47: 156-9.